HLA-DR Expression in Large Bowel Carcinomas and Patient Survival
Author Information
Author(s): S. Norheim Andersen, T.O. Rognum, E. Lund, G.I. Meling, S. Haugel
Primary Institution: Institute of Forensic Medicine, The National Hospital, University of Oslo, and Institute of Community Medicine, University of Tromso, Norway.
Hypothesis
Is there a prognostic significance of HLA-DR expression in large bowel carcinomas?
Conclusion
Strong HLA-DR expression in large bowel carcinomas is associated with better survival outcomes.
Supporting Evidence
- Patients with strong HLA-DR expression had the best survival rates.
- Statistical analysis showed significant differences in survival based on HLA-DR expression levels.
- The study included a follow-up period of over 10 years.
Takeaway
This study found that patients with certain types of bowel cancer who had strong HLA-DR expression in their tumors lived longer than those who did not.
Methodology
Immunohistochemical analysis of HLA-DR expression in tumor samples from 100 patients, followed by survival analysis.
Potential Biases
Potential observer bias in scoring HLA-DR expression.
Limitations
The study is limited by its retrospective nature and the subjective scoring of HLA-DR expression.
Participant Demographics
Mean age of participants was 64.5 years, with 52 men and 48 women.
Statistical Information
P-Value
0.006
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website